Long-term low-dose amiodarone therapy in the management of ventricular and supraventricular tachyaithythmias: Efficacy and safety

Clinical Cardiology

Volumn 20, Issue 4, 1997, Pages 372-377

  Lee, Kathy L ^a   Tai, Yau Ting ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Amiodarone hydrochloride; Low maintenance dose; Supraventricular arrhythmias; Ventricular arrhythmias

Indexed keywords

AMIODARONE;

ADULT; AGED; ARTICLE; DRUG EFFICACY; FEMALE; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERTHYROIDISM; INTRAVENOUS DRUG ADMINISTRATION; LIVER TOXICITY; LUNG FIBROSIS; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; SUPRAVENTRICULAR TACHYCARDIA;

EID: 0030902276     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960200414     Document Type: Article

References (21)

1. Rosenbaum MB, Chiale PA, Ryba D, Elizari MV: Control oftachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochloride. Am J Cardiol 1974;4:215-223
2. Mason JW: Drug therapy: Amiodarone. N Engl J Med 198;316: 455-466
3. Greene HL, Graham EL, Werner JA, Sears GK, Gorham JR, Kudenchuk PJ, Trobaugh GB: Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias. J Am Coll CW/o/1983;2:1114-1128
4. Fogoros RN, Andersen KP, Winkle RA, Swerdlow CD, Mason JW: Amiodarone: Clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias. Circulation 1983;68:88-94
5. Smith WM, Lubbe WF, Whitlock RM, Mercer J, Rutherford JR, Roche AH: Long term tolerance of amiodarone treatment for cardiac arrhythmias! Am J Cardiol 1986;57:1288-1293
6. Herre JM, Sauve MJ, Malone P, Griffin JC, Helmy I, Langberg JJ, Goldberg H, Scheinman MM: Long-ferm results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation. JAm CoHCardiol 1989;13:442-449
7. Harris L, McKenna WJ, Rowland E, Krikler DM: Amiodarone: Side effects of long-term therapy. Circulation 1983;67:45-51
8. McGovern B, Garan H, Kelly E, Ruskin JN: Adverse reactions during treatment with amiodarone hydrochloride. BrMcdJ 1983;287: 175-180
9. Wilson JS, Podrid PJ: Side effects from amiodarone. Am Heart J 1991:121:158-171
10. Singh BN: Arrhythmia control by prolonging repolarization: The concept and its potential therapeutic impact. Eur Heart J 1993; 14(suppl 15): 14-23
11. Kowey PR, FriehlingTD.Marinchak RA, Sulpizi AM: StohlerJL: Safety and efficacy of amiodarone: The low-dose perspective. Chest 1988;93:54-59
12. Weinberg B A, Miles WM, Klein LS, Bolander JE, Dusnian RE, Stanton MS, Heger JJ, Langefeld C, Zipes DP: Five-year follow-up of 589 patients treated with amiodarone. Am Heart J 1993;125: 109-120
13. Middlekauff HR, Wiener I, Stevenson WG: Low-dose amiodarone foratrial fibrillation. Am J Canliol 1993;72:75F-81F
14. Gosselink ATM, Crijns HJGM, Van Gelder 1C, Hilligc H. Wiesfeld CP, Lie KI: Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter. JAin MedAssoc 1992;267:3289-3293
15. Scheinman MM: NASPE policy statement: NASPE survey on catheter ablation. PACE 1995;18:1474-1478
16. CASCADE Investigators: Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study). Am J Cardiol 1993;72:280-287
17. Siebeis J, Cappato R,- Ruppel R, Schneider MAE, Kuck KH, and the CASH Investigators: Preliminary results of the Cardiac Arrest Study Hamburg (CASH). Am J Cardiol 1993;72:109F-113F
18. Singh BN: Choice and chance in drug therapy of cardiac arrhythmias: Technique versus drug-specific responses in evaluation of efficacy. Am J Ccinliol 1993;72:114F-124F
19. Pfisterer ME, Kiowski W, Brunner H, Burckhardt D, Burkart F: Long-term benefit of 1-year amiodarone treatment for persistent complex ventricular arrhythmias after myocardial infarction. Circulation 1993;87:309-311
20. Ceremuzynski L, Kleczar E, Krzeminska-Pakula M, Kuch J, Nartowicz E, Smielak-Korombel J, Dyduszynski A, Maciejewicz J, Zaleska T, Lazarczyk-Keedzia E, Motyka J, Paczkowska B, Sczaniecka O, Yüsuf S: Effect of amiodarone on mortality after myocardial infarction: A double-blind, placebo-controlled, pilot sludy.JAmCollCanliol 1992;20:1056-1062
21. Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R: Randomized trial of low-dose amiodarone in severe congestive heart failure. Lancet 1994;34:493-498